Tech Company M&A Transactions
Crescendo Bioscience Acquisition
Based in South San Francisco, Crescendo Bioscience was acquired by Myriad Genetics. The transaction price was $245 million.
Transaction Overview
Company Name
Acquired By
Announced On
2/4/2014
Transaction Type
M&A
Amount
$245,000,000
M&A Terms
Myriad Genetics, Inc. announced today that it has entered into a definitive agreement to acquire Crescendo Bioscience, Inc., a global leader in autoimmune diagnostics, for $270 million in cash which will be reduced by $25 million for the repayment of a loan made to Crescendo and customary adjustments in accordance with the acquisition agreement.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
341 Oyster Point Blvd
South San Francisco, CA 94080
USA
South San Francisco, CA 94080
USA
Phone
Website
Email Address
Not Recorded
Overview
Crescendo Bioscience is developing a broad range of quantitative, objective diagnostic tools to provide Rheumatologists with deeper clinical insights to more effectively manage patients with autoimmune and inflammatory diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
William Hagstrom
Chief Information Officer
Alex Bangs
Chief Medical Officer
Oscar Segurado
Chief Operating Officer
Brian Bertha
VP - Bus. Development
Lucy Lu
VP - Finance
Timothy Henn
VP - Sales
Erik Harris
Browse more venture capital transactions:
Prev: 2/4/2014: Primus Power venture capital transaction
Next: 2/4/2014: Snap venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs